Cerebral Oximetry Monitoring Market

By Product Type;

Systems/Consoles and Disposable Sensors & Accessories

By Technology;

Continuous-Wave NIRS and Others

By Application;

Cardiac Surgery, Vascular Surgery and Others

By End User;

Hospital & Clinics, Ambulatory Surgical Centers and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn100379585 Published Date: August, 2025 Updated Date: September, 2025

Cerebral Oximetry Monitoring Market Overview

Cerebral Oximetry Monitoring Market (USD Million)

Cerebral Oximetry Monitoring Market was valued at USD 196.19 million in the year 2024. The size of this market is expected to increase to USD 317.11 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.


Cerebral Oximetry Monitoring Market

*Market size in USD million

CAGR 7.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.1 %
Market Size (2024)USD 196.19 Million
Market Size (2031)USD 317.11 Million
Market ConcentrationMedium
Report Pages390
196.19
2024
317.11
2031

Major Players

  • Masimo
  • Medtronic
  • Edwards Lifesciences Corporation
  • Nonin
  • ISS, Inc.
  • Hamamatsu Photonics K.K.
  • Mespere LifeSciences
  • GE Healthcare
  • Terumo Cardiovascular Systems Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cerebral Oximetry Monitoring Market

Fragmented - Highly competitive market without dominant players


The Cerebral Oximetry Monitoring Market is expanding as the demand for continuous brain oxygen monitoring grows in critical care and surgical environments. Studies show that nearly 32% of patients undergoing complex surgeries face risks of cerebral hypoxia, emphasizing the necessity of real-time monitoring. This rising dependence on cerebral oximetry is creating strong opportunities for market growth.

Technological Advancements in Monitoring
Innovations in near-infrared spectroscopy (NIRS) and other non-invasive monitoring techniques are driving significant changes in the market. Over 40% of recently launched devices focus on improved precision, wireless features, and enhanced portability. These advancements are enabling faster clinical decision-making and positioning cerebral oximetry as a vital tool in modern healthcare.

Expanding Use in Surgical and Critical Care
The adoption of cerebral oximetry is increasing across cardiac procedures, neurosurgeries, and intensive care units. Reports suggest that nearly 45% of surgical teams now utilize cerebral oximetry as a standard practice during operations. This widespread use underscores its role in lowering post-operative risks, minimizing complications, and improving patient outcomes.

Clinical Benefits and Rising Awareness
Greater awareness of the advantages of cerebral oxygen monitoring is boosting demand among healthcare professionals. Clinical findings indicate that continuous monitoring can cut the rate of adverse neurological events by up to 28%, ensuring better patient recovery. As awareness spreads, hospitals and specialty centers are increasingly integrating these devices into routine protocols.

Supportive Investments and Healthcare Policies
Growing healthcare funding and favorable policy frameworks are broadening access to advanced monitoring technologies. More than 38% of healthcare programs now include neurological monitoring as a core component of critical care. Coupled with ongoing technological innovation, these supportive initiatives are reinforcing the long-term growth outlook for the cerebral oximetry monitoring market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Cerebral Oximetry Monitoring Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Cardiovascular and Neurological Disorders

        2. Technological Advancements in Cerebral Oximetry Devices

        3. Growing Adoption of Minimally Invasive Surgical Procedures

        4. Rising Geriatric Population and Surgical Procedures

        5. Regulatory Approvals and Initiatives for Patient Safety

      2. Restraints
        1. High Cost of Cerebral Oximetry Devices

        2. Limited Awareness and Adoption in Developing Regions

        3. Technological Limitations and Accuracy Concerns

        4. Regulatory Challenges and Compliance Issues

      3. Opportunities
        1. Advancements in Device Technology

        2. Increasing Demand for Minimally Invasive Surgeries

        3. Growing Adoption in Emerging Markets

        4. Integration with Other Monitoring Systems

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cerebral Oximetry Monitoring Market, By Product Type, 2021 - 2031 (USD Million)

      1. Systems/Consoles

      2. Disposable Sensors & Accessories

    2. Cerebral Oximetry Monitoring Market, By Technology, 2021 - 2031 (USD Million)

      1. Continuous-Wave NIRS

      2. Others

    3. Cerebral Oximetry Monitoring Market, By Application, 2021 - 2031 (USD Million)
      1. Cardiac Surgery
      2. Vascular Surgery
      3. Others
    4. Cerebral Oximetry Monitoring Market, By End User, 2021 - 2031 (USD Million)
      1. Hospital & Clinics
      2. Ambulatory Surgical Centers
      3. Others
    5. Cerebral Oximetry Monitoring Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Masimo
      2. Medtronic
      3. Edwards Lifesciences Corporation
      4. Nonin
      5. ISS, Inc.
      6. Hamamatsu Photonics K.K.
      7. Mespere LifeSciences
      8. GE Healthcare
      9. Terumo Cardiovascular Systems Corporation
  7. Analyst Views
  8. Future Outlook of the Market